Barclays »

Coeptis Therapeutics Hldgs I shares owned by Barclays

Quarter-by-quarter ownership of Coeptis Therapeutics Hldgs I (COEP) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Coeptis Therapeutics Hldgs I

Tip: Access up to 7 years of quarterly data

All positions including Coeptis Therapeutics Hldgs I held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Coeptis Therapeutics Hldgs I by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $51 3 17.33
2025-06-30 $0 3 0.00
2025-03-31 $0 3 0.00

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Coeptis Therapeutics Hldgs I

Vanguard Group
Geode Capital Management
State Street Corporation
Renaissance Technologies
Yorkville Advisors Global
Steward Partners Investment Advisory
Pnc Financial Services
Barclays

View all funds holding Coeptis Therapeutics Hldgs I